Mosaic ImmunoEngineering (CPMV) Price to Book (2013 - 2026)

Mosaic ImmunoEngineering has reported Price to Book for 14 years, with the latest figure at 0.71 in Q1 2026.

• On a quarterly basis, Price to Book rose 12.42% year-over-year to 0.71 in Q1 2026; TTM through Mar 2026 was 0.71, a 12.42% increase from a year earlier, with the FY2025 full-year figure at 0.02, up 103.01% from the prior year.
• Price to Book was 0.71 for Q1 2026 at Mosaic ImmunoEngineering, down from 0.02 in the prior quarter.
• The five-year high for Price to Book was 0.02 in Q4 2025, with the low at 3.06 in Q2 2022.
• Average Price to Book over 5 years is 1.01, with a median of 0.75 recorded in 2024.
• The largest YoY upside for Price to Book was 103.01% in 2025 against a maximum downside of 115.25% in 2025.
• Over 5 years, Price to Book stood at 1.47 in 2022, then surged by 49.58% to 0.74 in 2023, then retreated by 0.9% to 0.75 in 2024, then soared by 103.01% to 0.02 in 2025, then sank by 3261.99% to 0.71 in 2026.
• The last three Price to Book figures came in at 0.71 (Q1 2026), 0.02 (Q4 2025), and 0.69 (Q3 2025), per Business Quant data.